Li Y, Liu M, Zheng Y, Wang Z*, Zhao Y*, 2023. Coenzyme-depleting nanocarriers for enhanced redox cancer therapy under hypoxia. J Colloid Interface Sci, 641: 135-145.
点击次数:
上一条:Li Y, Feng M, Guo T, Wang Z, Zhao Y*, 2023. Tailored beta-lapachone nanomedicines for cancer-specific therapy. Adv Healthc Mater, 12(20): 2300349.
下一条:Wang Z, Mu X, Yang Q, Luo J, Zhao Y*, 2022. Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha. J Colloid Interface Sci, 628: 106-115.
